We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
MDI Launches New Version of Detect-Ready® MRSA Panel at ECCMID
Product News

MDI Launches New Version of Detect-Ready® MRSA Panel at ECCMID

MDI Launches New Version of Detect-Ready® MRSA Panel at ECCMID
Product News

MDI Launches New Version of Detect-Ready® MRSA Panel at ECCMID


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "MDI Launches New Version of Detect-Ready® MRSA Panel at ECCMID"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Molecular Detection Inc. (MDI) has announced that it will release a new version of its Detect-Ready MRSA Panel at the 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).

The superior performance of the Detect-Ready MRSA Panel has been further enhanced by increasing the number of MRSA strains it can detect, adding MRSA strains known to be missed by at least one other market-leading assay to the universe of all known common MRSA strains that were already included.

The new kit also shortens the sample preparation process and minimizes required “hands-on” time.

The Detect-Ready MRSA Panel is a qualitative real-time PCR in vitro diagnostic test. It is CE-marked for the detection of MRSA (methicillin-resistant Staphylococcus aureus) and MSSA (methicillin-sensitive S. aureus) and is the only marketed PCR-based MRSA screening test with the proven ability to discriminate accurately between these pathogens and other related bacteria.

“We are delighted to offer this improved version of the Detect-Ready MRSA Panel to our growing customer base,” commented David Wilson, MDI’s Vice President for Commercial Operations, Europe.

Wilson continued, “The inclusion of additional covered MRSA strains reinforces the superior performance of our existing test, which was recently reconfirmed in an independent comparative study with a market leading competitor. In addition, the simplicity and ease-of-use of Detect-Ready MRSA is further enhanced with our new streamlined protocol for sample prep.”

Comparative data confirming the greater accuracy of the Detect-Ready MRSA panel was generated by researchers at St. Thomas’ Hospital in London as part of an academic study.

The study compared the performance of MDI’s test and the Becton Dickinson GeneOhm MRSA PCR sold by BD Diagnostics.

The researchers concluded that the Detect-Ready MRSA assay is superior to the GeneOhm panel in terms of specificity, while still providing a more rapid screening service compared to traditional microbiology culture methods.

Detect-Ready kits are compatible with a number of the real time-PCR platforms currently found in most hospitals.

Samples for testing are simple to obtain using nasal swabs and the kit’s ready-to-use pre-mixed reagents require only the addition of patient sample to run the test, which provides results in less than three hours.

Unlike other tests that require special handling, Detect-Ready kits are off-the-shelf room temperature-stabilized and require no refrigeration.

Advertisement